This study aims to compare the effectiveness of three different home-based rehabilitation programs for patients with acute coronary syndrome (ACS). This randomized controlled trial will recruit 60 ACS patients, divided into three groups: a 12-week home rehabilitation group, a 6-week tele-rehabilitation followed by 6-week home rehabilitation group, and a 12-week tele-rehabilitation combined with home rehabilitation group. Patients will be assessed at baseline, and at 3, 6, and 12 months on physical health, cardiopulmonary function, and psychological well-being. The hypothesis is that home-based CR, particularly with tele-rehabilitation, will improve recovery and quality of life more effectively. The study aims to identify the most beneficial home rehabilitation strategy for ACS patients.
This study is designed to evaluate the benefits of three different home-based cardiac rehabilitation (CR) models on the recovery of patients with acute coronary syndrome (ACS). Cardiovascular diseases are a major cause of mortality worldwide, but advancements in CR have significantly improved patient outcomes. Despite the proven benefits of CR in enhancing quality of life and reducing hospital readmission rates, participation in traditional CR programs remains low. Home-based CR, especially using tele-rehabilitation technologies, offers a promising alternative. This randomized controlled trial will recruit 60 ACS patients, divided into three groups: a 12-week home rehabilitation group, a 6-week tele-rehabilitation followed by a 6-week home rehabilitation group, and a 12-week tele-rehabilitation combined with home rehabilitation group. All patients will undergo evaluations at baseline, and at 3, 6, and 12 months to assess physical health, cardiopulmonary function, and psychological well-being. The hypothesis is that home-based CR, particularly with tele-rehabilitation support, will enhance recovery and quality of life more effectively than traditional methods. The findings aim to identify the most effective home rehabilitation strategy for ACS patients, providing insights into improving their cardiopulmonary function and overall well-being.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Twice-weekly sessions with remote supervision and guidance from therapists.
Health education based on individual assessments.
Exercise prescription tailored to individual needs.
Use of a home exercise bike, resistance bands, respiratory muscle training device, and a portable heart rate monitor.
Logging daily exercise intensity and duration in a rehabilitation diary
Regular follow-up calls to monitor progress and address any issues.
Maximal Oxygen Uptake (VO2 max)
his measure will evaluate cardiopulmonary function by assessing the maximal oxygen uptake (VO2 max). VO2 max is the maximum amount of oxygen the body can utilize during intense exercise and is an indicator of cardiovascular and respiratory efficiency.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
Anaerobic Threshold
This measure will evaluate cardiopulmonary function by assessing the anaerobic threshold. The anaerobic threshold is the exercise intensity at which lactate begins to accumulate in the blood, indicating the transition from aerobic to anaerobic metabolism.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
Oxygen Pulse
This measure will evaluate cardiopulmonary function by assessing the oxygen pulse, which is the amount of oxygen used by the body per heartbeat during exercise. It provides insights into cardiovascular efficiency and respiratory function.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
Muscle strength
This measure will assess physical function through the muscle strength tests (manual muscle testing). These tests will evaluate improvements in participants' muscular strength and endurance by measuring the maximum force that muscles can exert against resistance.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
Six-Minute Walk Test (6MWT)
This measure will assess physical function through the six-minute walk test (6MWT). The test evaluates improvements in participants' walking endurance and overall physical capabilities.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
Sit-to-Stand Test
This measure will assess physical function through the sit-to-stand test. The test evaluates improvements in participants' lower body strength and functional mobility. This measure will assess physical function through the sit-to-stand test. The test evaluates improvements in participants' lower body strength and functional mobility. This measure will assess physical function through the sit-to-stand test. The test evaluates improvements in participants' lower body strength and functional mobility.
Time frame: Assessments will be conducted at baseline (week 0), and at 3, 6, and 12 months post-intervention.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.